Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer

NCT05624138 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT05624138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05624138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer
Lead sponsor
Tanta University
Phase
Phase 3
Overall status
Recruiting
Start date
November 9, 2022
Completion date
June 30, 2025
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathy;peripheral